Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats.

[1]  D. Trono,et al.  A Simple and Highly Effective Method for the Stable Transduction of Uncultured Porcine Hepatocytes Using Lentiviral Vector , 2005, Cell transplantation.

[2]  A. Beaudet,et al.  Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Ferry,et al.  Liver gene therapy: advances and hurdles , 2004, Gene therapy.

[4]  T. O'Malley,et al.  In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  A. Annoni,et al.  Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. , 2004, Blood.

[6]  J. Seppen,et al.  Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Adam Bagg,et al.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.

[8]  S. Cai,et al.  Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B. , 2003, Blood.

[9]  D. Trono,et al.  Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. , 2003, Blood.

[10]  S. Lee,et al.  A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler–Najjar syndrome , 2002, Gene Therapy.

[11]  D. Aubert,et al.  Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  D. Strayer,et al.  A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. , 2000, Gastroenterology.

[13]  L. Ailles,et al.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.

[14]  Luc Montagnier,et al.  HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.

[15]  T. Hope,et al.  Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors , 1999, Journal of Virology.

[16]  S. Strom,et al.  Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. , 1998, The New England journal of medicine.

[17]  B. A. French,et al.  Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1. , 1998, Human gene therapy.

[18]  J. Roy-Chowdhury,et al.  Transient immunosuppression with FK506 permits long‐term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat , 1997, Hepatology.

[19]  G. Droguett,et al.  Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Droguett,et al.  Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. , 1997, The Journal of clinical investigation.

[21]  M. Horwitz,et al.  Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. , 1996, The Journal of clinical investigation.

[22]  M. Horwitz,et al.  Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period* , 1996, The Journal of Biological Chemistry.

[23]  F. Askari,et al.  Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. , 1996, Gene therapy.

[24]  J. Roy-Chowdhury,et al.  Molecular basis for the lack of bilirubin-specific and 3-methylcholanthrene-inducible UDP-glucuronosyltransferase activities in Gunn rats. The two isoforms are encoded by distinct mRNA species that share an identical single base deletion. , 1991, The Journal of biological chemistry.

[25]  R. Costa,et al.  Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. , 1991, Nucleic acids research.

[26]  S. Kashiwamata,et al.  Genetic defect of bilirubin UDP-glucuronosyltransferase in the hyperbilirubinemic Gunn rat. , 1991, Biochemical and biophysical research communications.

[27]  W. van Steenbergen,et al.  Effects of uridine diphosphate glucuronosyltransferase activity on the maximal secretion rate of bilirubin conjugates in the rat. , 1990, Gastroenterology.

[28]  S. Kashiwamata,et al.  Isolation and sequencing of rat liver bilirubin UDP-glucuronosyltransferase cDNA: possible alternate splicing of a common primary transcript. , 1990, Biochemical and biophysical research communications.

[29]  P. Capel,et al.  Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase. , 1987, Gastroenterology.

[30]  N. Blanckaert,et al.  Liquid-chromatographic assay and identification of mono- and diester conjugates of bilirubin in normal serum. , 1983, Clinical chemistry.

[31]  C. H. Gunn.  HEREDITARY ACHOLURIC JAUNDICEin a New Mutant Strain of Rats , 1938 .

[32]  P. Bosma,et al.  Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.